These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15695728)

  • 1. Nalidixic acid-resistant Salmonella enterica serotype Typhi presenting as a primary psoas abscess: case report and review of the literature.
    Shakespeare WA; Davie D; Tonnerre C; Rubin MA; Strong M; Petti CA
    J Clin Microbiol; 2005 Feb; 43(2):996-8. PubMed ID: 15695728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India.
    Kownhar H; Shankar EM; Rajan R; Rao UA
    J Med Microbiol; 2007 Jan; 56(Pt 1):136-137. PubMed ID: 17172529
    [No Abstract]   [Full Text] [Related]  

  • 4. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA; Barrett TJ; Nelson JT; Angulo FJ
    Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
    Kim DM; Neupane GP; Jang SJ; Kim SH; Lee BK
    Int J Antimicrob Agents; 2010 Aug; 36(2):155-8. PubMed ID: 20478696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India.
    Kumar Y; Sharma A; Mani KR
    J Infect Dev Ctries; 2009 Jul; 3(6):467-9. PubMed ID: 19762961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Detection of
    Habeeb Rasool K; Hammood Hussein N; Mahamed Taha B
    Pak J Biol Sci; 2020 Jan; 23(10):1303-1309. PubMed ID: 32981264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM; Seema DS; Bhat GK; Shivananda PG
    Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
    Nkemngu NJ; Asonganyi ED; Njunda AL
    BMC Infect Dis; 2005 Jun; 5():49. PubMed ID: 15969764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
    Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
    Gaborieau V; Weill FX; Marchou B
    Med Mal Infect; 2010 Dec; 40(12):691-5. PubMed ID: 20724089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
    Nathania I; Nainggolan IM; Yasmon A; Nusatia ACM; Tjoa E; Gunardi WD; Moehario LH
    BMC Microbiol; 2022 Oct; 22(1):250. PubMed ID: 36253712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
    Kadhiravan T; Wig N; Kapil A; Kabra SK; Renuka K; Misra A
    BMC Infect Dis; 2005 May; 5():37. PubMed ID: 15904505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
    Rahman MM; Haq JA; Morshed MA; Rahman MA
    Int J Antimicrob Agents; 2005 Apr; 25(4):345-6. PubMed ID: 15784317
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.
    Crump JA; Kretsinger K; Gay K; Hoekstra RM; Vugia DJ; Hurd S; Segler SD; Megginson M; Luedeman LJ; Shiferaw B; Hanna SS; Joyce KW; Mintz ED; Angulo FJ;
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1278-84. PubMed ID: 18212096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).
    Singhal L; Gupta PK; Kale P; Gautam V; Ray P
    Indian J Med Microbiol; 2014; 32(2):149-52. PubMed ID: 24713900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
    Acharya D; Trakulsomboon S; Madhup SK; Korbsrisate S
    Jpn J Infect Dis; 2012; 65(3):264-7. PubMed ID: 22627312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
    Mutai WC; Muigai AWT; Waiyaki P; Kariuki S
    BMC Microbiol; 2018 Nov; 18(1):187. PubMed ID: 30428828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.